Thiogenesis Therapeutics: Top 10 Undervalued Biotechnology Industry Stocks (TTI)
Thiogenesis Therapeutics is now ranked among the top 10 undervalued stocks in the Biotechnology industry on the Toronto Stock Exchange or TSX Venture Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Biotechnology: Biotech and biopharmaceutical companies engaged in research, discovery, development, and production of innovative drug and drugrelated technologies.
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| QPT | Quest PharmaTech | 0.04 | 0.10 | 0.06 (185.6%) | 62778 | 5.9 | 0.0 | 0.0 |
| RVX | Resverlogix | 0.06 | 0.11 | 0.05 (88.6%) | 42034 | 16.5 | 0.0 | 0.0 |
| CSCI | Cosciens Biopharma | 4.12 | 5.98 | 1.86 (45.0%) | 2428 | 12.8 | 0.0 | 0.0 |
| HEM | Hemostemix | 0.08 | 0.11 | 0.03 (37.2%) | 69253 | 7.0 | 0.0 | 0.0 |
| MRVL | Marvel Biosciences | 0.17 | 0.22 | 0.05 (33.0%) | 99451 | 6.6 | 0.0 | 0.0 |
| TH | Theratechnologies | 1.67 | 2.06 | 0.39 (23.2%) | 60085 | 82.5 | 0.0 | 0.0 |
| APLI | Appili Therapeutics | 0.04 | 0.04 | 0.01 (22.8%) | 166661 | 4.2 | 0.0 | 0.0 |
| MBX | Microbix Biosystems | 0.30 | 0.36 | 0.06 (21.4%) | 164555 | 41.3 | 0.0 | 8.2 |
| TTI | Thiogenesis Therapeutics | 0.63 | 0.75 | 0.12 (18.9%) | 20299 | 28.7 | 0.0 | 0.0 |
| RKV | Rakovina Therapeutics | 0.06 | 0.07 | 0.01 (18.6%) | 101677 | 3.9 | 0.0 | 0.0 |
All data provided as of November 25, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Thiogenesis Therapeutics
Thiogenesis Therapeutics Corp is a clinical-stage biotech company. The Company is developing thiol-active therapeutic compounds, that are prodrugs, used to treat unmet pediatric medical needs. TTI-0102, the Company's compound, was developed to address the obstacles facing previous thiol-based drugs, their short half-live, and side effects and it's initial applications are for mitochondrial disease, Rett syndrome, and pediatric NASH.
Thiogenesis Therapeutics is listed under TTI on the TSX Venture Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
